2024 annual financial data
BioLineRx 2024 Operating margin
BioLineRx 2024 operating margin with verified reported values.
Direct answer
Operating margin was -70.52%.
Operating income was -20,408,000 USD and net income was -9,221,000 USD.
Operating cash flow was -43,873,000 USD.
Get free BioLineRx email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 28,940,000 USD
- Operating income
- -20,408,000 USD
- Net income
- -9,221,000 USD
- Operating cash flow
- -43,873,000 USD